Video - Post-transplant lymphoproliferative disorders (NORD)
00:00 / 00:00
More Videos
07:17
Isolated primary immunoglobulin M deficiency
07:36
Selective immunoglobulin A deficiency
05:15
X-linked agammaglobulinemia
05:37
Adenosine deaminase deficiency
06:20
Ataxia-telangiectasia
07:44
Hyper IgM syndrome
08:52
Wiskott-Aldrich syndrome
07:21
Complement deficiency
06:57
Chronic granulomatous disease
06:56
Leukocyte adhesion deficiency
05:05
DiGeorge syndrome
07:53
Thymic aplasia
Video Summary
Post-transplant lymphoproliferative disorders (PTLDs) are a group of lymphoid neoplasms characterized by uncontrolled growths of lymphocytes. It occurs after someone has received a solid organ or stem cell transplant that requires immunosuppressive medications to prevent transplant rejection. PTLDs are caused by Epstein-Barr virus (EBV) infection and can originate in either type of lymphocyte: B-cells or T-cells. Diagnosis involves blood tests, a biopsy, and imaging, while treatment may include surgery, chemotherapy, and radiation.
For Institutions
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.
